A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder

Clinical trial NCT07028697 · COMPLETED

Trial details

NCT number: NCT07028697
Sponsor: Nxera Pharma Korea Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Insomnia Disorder

Start date: 2024-12-04
Primary completion: 2025-09-23
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.